cabozantinib,atezolizumab
roche
['contact03', 'cabo ', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo', 'cabozantinib']
efficacy and safety of atezolizumab + cabozantinib vs cabo alone after progression with prior ici treatment in #mrcc: primary pfs analysis from the phase 3, randomized, open-label #contact03 study. presented by &gt; #asco23 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology